Digital medicine firm physIQ has collaborated with Purdue University for the development of a smartwatch-based algorithm to detect early viral infection signs, including signs of Covid-19.

As part of the partnership, physIQ will be responsible for the commercialisation of the algorithm. Purdue University biomedical engineering associate professor Craig Goergen led the research.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The research involved a study, which was conducted on 100 subjects, including Purdue students and staff, to determine whether wearing a smartwatch to gather data was practical and user-friendly.

A Samsung Galaxy smartwatch with a pre-loaded physIQ app was provided to the subjects for gathering data, along with US Food and Drug Administration (FDA)-cleared adhesive chest-based biosensors to measure heart rate, respiration rate and heart rate variability.

Using physIQ’s Cloud-based accelerateIQ platform, Goergen’s lab evaluated the data obtained from the app, which collects physiological data from patients remotely.

Goergen said: “Infections can happen at any time, making the continuously tracked data available through an individual’s smartwatches uniquely suited to identify the earliest signs of illness.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

“In particular, knowledge of a person’s usual heart rate and respiratory during sleep and activity over long periods of time is especially valuable for detecting subtle changes from normal.”

physIQ stated that the partnership with Purdue University advances the expansion of other smartwatch-based health care monitoring applications.

physIQ chief science officer Stephan Wegerich said: “The algorithms for enabling early detection are built off physiological features derived from the biosensor data collected by the smartwatches.

“Generating accurate and robust physiological features forms the input to subsequent viral detection algorithms.

“This requires the development of sophisticated signal processing and machine learning algorithms. Combined, these make the most out of smartwatch biosensor data, which is a big part of our collaboration with Purdue.”

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact